Literature DB >> 17204595

A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.

Jun-Seop Shin1, Tracy P Torres, Reetta L Catlin, E P Donahue, Masakazu Shiota.   

Abstract

Effect of stimulation of glucokinase (GK) export from the nucleus by small amounts of sorbitol on hepatic glucose flux in response to elevated plasma glucose was examined in 6-h fasted Zucker diabetic fatty rats at 10 wk of age. Under basal conditions, plasma glucose, insulin, and glucagon were approximately 8 mM, 2,000 pmol/l, and 60 ng/l, respectively. Endogenous glucose production (EGP) was 44 +/- 4 micromol x kg(-1) x min(-1). When plasma glucose was raised to approximately 17 mM, GK was still predominantly localized with its inhibitory protein in the nucleus. EGP was not suppressed. When sorbitol was infused at 5.6 and 16.7 micromol x kg(-1) x min(-1), along with the increase in plasma glucose, GK was exported to the cytoplasm. EGP (23 +/- 19 and 12 +/- 5 micromol x kg(-1) x min(-1)) was suppressed without a decrease in glucose 6-phosphatase flux (145 +/- 23 and 126 +/- 16 vs. 122 +/- 10 micromol x kg(-1) x min(-1) without sorbitol) but increased in glucose phosphorylation as indicated by increases in glucose recycling (122 +/- 17 and 114 +/- 19 vs. 71 +/- 11 microl x kg(-1) x min(-1)), glucose-6-phosphate content (254 +/- 32 and 260 +/- 35 vs. 188 +/- 20 nmol/g liver), fractional contribution of plasma glucose to uridine 5'-diphosphate-glucose flux (43 +/- 8 and 42 +/- 8 vs. 27 +/- 6%), and glycogen synthesis from plasma glucose (20 +/- 4 and 22 +/- 5 vs. 9 +/- 4 mumol glucose/g liver). The decreased glucose effectiveness to suppress EGP and stimulate hepatic glucose uptake may result from failure of the sugar to activate GK by stimulating the translocation of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17204595     DOI: 10.1152/ajpregu.00260.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  10 in total

1.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

2.  Fish oil normalizes plasma glucose levels and improves liver carbohydrate metabolism in rats fed a sucrose-rich diet.

Authors:  Gustavo J Hein; Adriana Chicco; Yolanda B Lombardo
Journal:  Lipids       Date:  2011-11-02       Impact factor: 1.880

3.  Glucotoxicity targets hepatic glucokinase in Zucker diabetic fatty rats, a model of type 2 diabetes associated with obesity.

Authors:  Kiichiro Ueta; Tracy P O'Brien; Gregory A McCoy; Kuikwon Kim; Erin C Healey; Tiffany D Farmer; E Patrick Donahue; Audree B Condren; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-08       Impact factor: 4.310

4.  Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.

Authors:  Kirsty S Cullen; Ziad H Al-Oanzi; Finbarr P M O'Harte; Loranne Agius; Catherine Arden
Journal:  Biochim Biophys Acta       Date:  2014-02-22

5.  Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.

Authors:  David J Lloyd; David J St Jean; Robert J M Kurzeja; Robert C Wahl; Klaus Michelsen; Rod Cupples; Michelle Chen; John Wu; Glenn Sivits; Joan Helmering; Renée Komorowski; Kate S Ashton; Lewis D Pennington; Christopher Fotsch; Mukta Vazir; Kui Chen; Samer Chmait; Jiandong Zhang; Longbin Liu; Mark H Norman; Kristin L Andrews; Michael D Bartberger; Gwyneth Van; Elizabeth J Galbreath; Steven L Vonderfecht; Minghan Wang; Steven R Jordan; Murielle M Véniant; Clarence Hale
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

6.  Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.

Authors:  Matthew G Rees; David Ng; Sarah Ruppert; Clesson Turner; Nicola L Beer; Amy J Swift; Mario A Morken; Jennifer E Below; Ilana Blech; James C Mullikin; Mark I McCarthy; Leslie G Biesecker; Anna L Gloyn; Francis S Collins
Journal:  J Clin Invest       Date:  2011-12-19       Impact factor: 14.808

7.  Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Yuka Fujimoto; E P Donahue; Richard L Printz; Karen L Houseknecht; Judith L Treadway; Masakazu Shiota
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

8.  Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle.

Authors:  Tracy P O'Brien; Erin C Jenkins; Shanea K Estes; Antonio V Castaneda; Kiichiro Ueta; Tiffany D Farmer; Allison E Puglisi; Larry L Swift; Richard L Printz; Masakazu Shiota
Journal:  Diabetes       Date:  2017-02-28       Impact factor: 9.461

9.  Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.

Authors:  Tracy P Torres; Reetta L Catlin; Robert Chan; Yuka Fujimoto; Noriyasu Sasaki; Richard L Printz; Christopher B Newgard; Masakazu Shiota
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

10.  Targeting hepatic glucokinase in type 2 diabetes: weighing the benefits and risks.

Authors:  Loranne Agius
Journal:  Diabetes       Date:  2009-01       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.